NCT03697590

Brief Summary

Guidelines for photodynamic therapy (PDT) of actinic keratosis recommend pretreatment with curettage. The impact of curettage on the treatment effect is, however, not known. The present study aimed to evaluate whether daylight-PDT without curettage would reduce treatment effect compared to daylight-PDT with curettage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jun 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 4, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 5, 2018

Completed
Last Updated

October 9, 2018

Status Verified

June 1, 2017

Enrollment Period

7 months

First QC Date

October 4, 2018

Last Update Submit

October 5, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complete lesion response rate

    Complete lesion response rate, was defined as the number of completely responding lesions divided by the total number of treated lesion in each field. Complete lesion response was defined as complete disappearance of the lesion both by palpation and visually.

    Treatment efficacy was evaluated 3 months after PDT

Study Arms (2)

PDT with no curettage

EXPERIMENTAL
Drug: No curettage

Standard PDT

ACTIVE COMPARATOR
Drug: Curettage

Interventions

Standard PDT without curettage

PDT with no curettage

Standard PDT

Standard PDT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Multiple actinic keratosis on the forehead or scalp

You may not qualify if:

  • Known allergy to methyl aminolevulinate
  • Porphyria
  • Pregnancy
  • Lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bispebjerg Hospital

Copenhagen NV, DK, 2400, Denmark

Location

MeSH Terms

Conditions

Keratosis, Actinic

Interventions

Curettage

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsKeratosisSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, MD, PhD

Study Record Dates

First Submitted

October 4, 2018

First Posted

October 5, 2018

Study Start

June 1, 2017

Primary Completion

December 20, 2017

Study Completion

December 20, 2017

Last Updated

October 9, 2018

Record last verified: 2017-06

Locations